by Jessica Casebolt | Jun 11, 2024 | Payers, Tea Leaves
The Centers for Medicare and Medicaid Services (CMS) must recalculate Anthem Blue Cross and Blue Shield of Georgia’s Medicare Advantage star ratings, a federal court ruled Friday. Parent company Elevance Health sued over its scores in December, alleging CMS did not...
by Jessica Casebolt | Jun 11, 2024 | Mental Health, Tea Leaves
Gun suicides consistently outstrip gun homicides in the U.S. despite drawing less attention than other forms of gun violence. Suicide rates have increased in the U.S. over the past few decades and become a leading cause of death among young and middle-aged Americans....
by Jessica Casebolt | Jun 11, 2024 | Life Sciences, Tea Leaves
A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration (FDA)...
by Jessica Casebolt | Jun 10, 2024 | Providers, Tea Leaves
Nearly three-quarters of health care professionals say the time or effort needed to complete clinical documentation hampers patient care, according to a survey published by the American Medical Informatics Association. Documentation tasks follow health care workers...
by Jessica Casebolt | Jun 10, 2024 | Payers, Tea Leaves
Humana and CVS, major players in the Medicare Advantage (MA) market, are anticipated to significantly reduce plan benefits and geographic coverage next year in pursuit of higher profits within the privately run Medicare program. This move could potentially lead to...
Recent Comments